Rheumatoid Arthritis Clinical Trials in New York

Showing 1861-1880 of 3,596 trials

Cannabinoids for Taxane Induced Peripheral Neuropathy

NCT03782402

Taxane-induced peripheral neuropathy (TIPN) affects a significant number of women undergoing breast cancer treatment. Some patients may need to shorten their course of treatment, and do not receive the full benefit of chemotherapy as a result. Rodent studies have shown that the cannabinoids may significantly improve hyperalgesia and allodynia induced by paclitaxel. The goal of this study is to investigate the cannabinoids THC and CBD for TIPN.

Chemotherapy-induced Peripheral Neuropathy

New York State Psychiatric Institute12 participantsStarted Sep 2019

New York, New York, United States

COMPLETEDPhase 1< 1 mile

Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration

NCT03347708

The purpose of this study is to compare the safety and preliminary efficacy of intradiscal injections of two doses of IDCT (Discogenic Cells + Sodium Hyaluronate vehicle) and two controls (saline, Sodium Hyaluronate vehicle) in subjects with chronic low back pain due to Degenerative Disc Disease (DDD) at one lumbar level from L3 to S1.

Degenerative Disc Disease

DiscGenics, Inc.60 participantsStarted Feb 2018

Birmingham, Alabama, United States • Los Angeles, California, United States • San Diego, California, United States +11 more locations

Cannabinoids for Taxane Induced Peripheral Neuropathy

Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration

Rheumatoid Arthritis Trials in Other Cities

Use of Antiretroviral (ARV) Drug Levels in Dried Blood Spots (DBS) to Assess and Manage ART Adherence in South Africa

Total Shoulder Arthroplasty Near-infrared Spectroscopy

Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission

Ipilimumab and/or Nivolumab in Combination With Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Trial on Endovascular Aneurysm Management

Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease

Efficacy, Tolerability, and Safety of DFN-15

Impact of Hidradenitis Suppurativa on Quality of Life Functions

Trial of Ultrasound Guidance for Reduction of Pediatric Forearm Fractures

Pembrolizumab, Belantamab and Dexamethasone in Refractory Multiple Myeloma.

Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)

Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)

Transepithelial (Epi-on) Corneal Collagen Crosslinking to Treat Keratoconus and Corneal Ectasia

Accelerated Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Pulse or Continuous UV-A Light

Speed of Processing Training to Improve Cognition in Traumatic Brain Injury and Mild Cognitive Impairment

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Outcome pRognostication of Acute Brain Injury With the NeuroloGical Pupil indEx

Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease

Other Conditions in New York